home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Advancements in AI for optimal clinical trial site identification: Turning Big Data into actionable intel

 
  July 31, 2023  
     
 
Xtalks, online
2023 -8-22


Despite advancing technologies, clinical trials still struggle to meet patient enrollment goals. Slow enrollment directly impacts schedule and budget, with each day of delay carrying cripplingly high costs. Successful, timely patient recruitment is directly linked to effective clinical trial site identification and selection. Conversely, selecting the wrong site can negatively impact recruitment or result in total failure to enroll patients.
 
Join the featured speaker to learn how advancements in AI can help pharma and biotech identify the best sites for their clinical trials through the harnessing of Big Data. Topics and learnings include:
 

Insights on transitioning from a state of data overload to one of data driven, informed decision-making
The role of artificial intelligence in optimising clinical trial site identification and selection
Expected and unexpected downstream benefits of an AI-enabled site selection strategy
 
 
Organized by: Xtalks
Invited Speakers: Travis Caudill, Vice President Feasibility, Site Identification & Clinical Informatics, ICON
 
Deadline for Abstracts: 2023 -8-22
 
Registration: Free registration
E-mail: ajuurinen@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.